MEI Pharma Inc.

NASDAQ: MEIP
Share price (12/27/24): $2.44
Market cap (12/27/24): $16.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 51 pages Asset Purchase Agreement Between Aardvark Therapeutics, Inc., as Purchaser and MEI Pharma, Inc., as Seller Dated as of October 22, 2024

from 8-K 134 pages Agreement and Plan of Merger Among Infinity Pharmaceuticals, Inc. MEI Pharma, Inc. and Meadow Merger Sub, Inc. Dated as of February 22, 2023

from 8-K 56 pages Asset Purchase Agreement by and Between MEI Pharma, Inc. as Purchaser, and S*bio Pte Ltd. as Seller Dated as of August 7, 2012

from SC 13G ~5 pages Joint Filing Agreement

from S-4/A 5 pages Amendment No. 1 to Asset Purchase Agreement

from 425 56 pages Asset Purchase Agreement Between Marshall Edwards, Inc., as Buyer, Novogen Limited, as Seller Parent, and Novogen Research Pty Limited, as Seller Dated as of December 21, 2010

from 8-K 56 pages Asset Purchase Agreement Between Marshall Edwards, Inc., as Buyer, Novogen Limited, as Seller Parent, and Novogen Research Pty Limited, as Seller Dated as of December 21, 2010